Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

1.

cDNA cloning and expression of an apoptosis-related gene, humanTFAR15 gene.

Wang Y, Liu H, Zhang Y, Ma D.

Sci China C Life Sci. 1999 Jun;42(3):323-9. doi: 10.1007/BF03183610.

PMID:
20229348
[PubMed]
2.

Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations.

Plummer NW, Squire TL, Srinivasan S, Huang E, Zawistowski JS, Matsunami H, Hale LP, Marchuk DA.

Mamm Genome. 2006 Feb;17(2):119-28. Epub 2006 Feb 7.

PMID:
16465592
[PubMed - indexed for MEDLINE]
3.

Patterns of expression of the three cerebral cavernous malformation (CCM) genes during embryonic and postnatal brain development.

Petit N, Blécon A, Denier C, Tournier-Lasserve E.

Gene Expr Patterns. 2006 Jun;6(5):495-503. Epub 2006 Feb 7.

PMID:
16455310
[PubMed - indexed for MEDLINE]
4.

CCM3 mutations are uncommon in cerebral cavernous malformations.

Verlaan DJ, Roussel J, Laurent SB, Elger CE, Siegel AM, Rouleau GA.

Neurology. 2005 Dec 27;65(12):1982-3.

PMID:
16380626
[PubMed - indexed for MEDLINE]
5.

CCM2 expression parallels that of CCM1.

Seker A, Pricola KL, Guclu B, Ozturk AK, Louvi A, Gunel M.

Stroke. 2006 Feb;37(2):518-23. Epub 2005 Dec 22.

PMID:
16373645
[PubMed - indexed for MEDLINE]
Free Article
6.

Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.

Liquori CL, Berg MJ, Squitieri F, Ottenbacher M, Sorlie M, Leedom TP, Cannella M, Maglione V, Ptacek L, Johnson EW, Marchuk DA.

Hum Mutat. 2006 Jan;27(1):118.

PMID:
16329096
[PubMed - indexed for MEDLINE]
7.

Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations.

Tu J, Stoodley MA, Morgan MK, Storer KP.

J Neurosurg. 2005 Nov;103(5):903-9.

PMID:
16304995
[PubMed - indexed for MEDLINE]
8.

CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis.

Zawistowski JS, Stalheim L, Uhlik MT, Abell AN, Ancrile BB, Johnson GL, Marchuk DA.

Hum Mol Genet. 2005 Sep 1;14(17):2521-31. Epub 2005 Jul 21.

PMID:
16037064
[PubMed - indexed for MEDLINE]
Free Article
9.

Neural guidance molecules regulate vascular remodeling and vessel navigation.

Eichmann A, Makinen T, Alitalo K.

Genes Dev. 2005 May 1;19(9):1013-21. Review.

PMID:
15879551
[PubMed - indexed for MEDLINE]
Free Article
10.

Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion.

Gault J, Shenkar R, Recksiek P, Awad IA.

Stroke. 2005 Apr;36(4):872-4. Epub 2005 Feb 17.

PMID:
15718512
[PubMed - indexed for MEDLINE]
Free Article
11.

Nuclear translocation of integrin cytoplasmic domain-associated protein 1 stimulates cellular proliferation.

Fournier HN, Dupé-Manet S, Bouvard D, Luton F, Degani S, Block MR, Retta SF, Albiges-Rizo C.

Mol Biol Cell. 2005 Apr;16(4):1859-71. Epub 2005 Feb 9.

PMID:
15703214
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Structural and evolutionary division of phosphotyrosine binding (PTB) domains.

Uhlik MT, Temple B, Bencharit S, Kimple AJ, Siderovski DP, Johnson GL.

J Mol Biol. 2005 Jan 7;345(1):1-20. Review.

PMID:
15567406
[PubMed - indexed for MEDLINE]
13.

No CCM2 mutations in a cohort of 31 sporadic cases.

Verlaan DJ, Laurent SB, Rouleau GA, Siegel AM.

Neurology. 2004 Nov 23;63(10):1979. No abstract available.

PMID:
15557534
[PubMed - indexed for MEDLINE]
14.

Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.

Bergametti F, Denier C, Labauge P, Arnoult M, Boetto S, Clanet M, Coubes P, Echenne B, Ibrahim R, Irthum B, Jacquet G, Lonjon M, Moreau JJ, Neau JP, Parker F, Tremoulet M, Tournier-Lasserve E; Société Française de Neurochirurgie.

Am J Hum Genet. 2005 Jan;76(1):42-51. Epub 2004 Nov 12.

PMID:
15543491
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations.

Morris PN, Dunmore BJ, Tadros A, Marchuk DA, Darland DC, D'Amore PA, Brindle NP.

J Mol Med (Berl). 2005 Jan;83(1):58-63. Epub 2004 Oct 29.

PMID:
15526080
[PubMed - indexed for MEDLINE]
16.

Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations.

Plummer NW, Gallione CJ, Srinivasan S, Zawistowski JS, Louis DN, Marchuk DA.

Am J Pathol. 2004 Nov;165(5):1509-18.

PMID:
15509522
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Search for loss of heterozygosity and mutation analysis of KRIT1 gene in CCM patients.

Marini V, Ferrera L, Pigatto F, Origone P, Garrè C, Dorcaratto A, Viale G, Alberti F, Mareni C.

Am J Med Genet A. 2004 Sep 15;130A(1):98-101. No abstract available.

PMID:
15368504
[PubMed - indexed for MEDLINE]
18.

Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis.

Guzeloglu-Kayisli O, Kayisli UA, Amankulor NM, Voorhees JR, Gokce O, DiLuna ML, Laurans MS, Luleci G, Gunel M.

J Neurosurg. 2004 May;100(5 Suppl Pediatrics):481-7.

PMID:
15287459
[PubMed - indexed for MEDLINE]
19.

CCM1 mutation screen of sporadic cases with cerebral cavernous malformations.

Verlaan DJ, Laurent SB, Sure U, Bertalanffy H, Andermann E, Andermann F, Rouleau GA, Siegel AM.

Neurology. 2004 Apr 13;62(7):1213-5.

PMID:
15079030
[PubMed - indexed for MEDLINE]
20.

KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.

Guzeloglu-Kayisli O, Amankulor NM, Voorhees J, Luleci G, Lifton RP, Gunel M.

Neurosurgery. 2004 Apr;54(4):943-9; discussion 949.

PMID:
15046662
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk